Report Detail
Global (United States, European Union and China) RNA-based Biopharmaceuticals Market Research Report 2019-2025
- RnM3446336 |
- 16 July, 2020 |
- Global |
- 154 Pages |
- QYResearch |
- Pharma & Healthcare
RNA-based Biopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA-based Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the RNA-based Biopharmaceuticals market is segmented into
Therapeutics
Vaccines
Segment by Application, the RNA-based Biopharmaceuticals market is segmented into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The RNA-based Biopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the RNA-based Biopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and RNA-based Biopharmaceuticals Market Share Analysis
RNA-based Biopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA-based Biopharmaceuticals business, the date to enter into the RNA-based Biopharmaceuticals market, RNA-based Biopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
1 Study Coverage
- 1.1 RNA-based Biopharmaceuticals Product Introduction
- 1.2 Market Segments
- 1.3 Key RNA-based Biopharmaceuticals Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type
- 1.4.2 Therapeutics
- 1.4.3 Vaccines
- 1.5 Market by Application
- 1.5.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application
- 1.5.2 Cancer
- 1.5.3 Diabetes
- 1.5.4 Tuberculosis
- 1.5.5 Cardiovascular Diseases
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global RNA-based Biopharmaceuticals Market Size, Estimates and Forecasts
- 2.1.1 Global RNA-based Biopharmaceuticals Revenue 2015-2026
- 2.1.2 Global RNA-based Biopharmaceuticals Sales 2015-2026
- 2.2 Global RNA-based Biopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global RNA-based Biopharmaceuticals Competitor Landscape by Players
- 3.1 RNA-based Biopharmaceuticals Sales by Manufacturers
- 3.1.1 RNA-based Biopharmaceuticals Sales by Manufacturers (2015-2020)
- 3.1.2 RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
- 3.2 RNA-based Biopharmaceuticals Revenue by Manufacturers
- 3.2.1 RNA-based Biopharmaceuticals Revenue by Manufacturers (2015-2020)
- 3.2.2 RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global RNA-based Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by RNA-based Biopharmaceuticals Revenue in 2019
- 3.2.5 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 RNA-based Biopharmaceuticals Price by Manufacturers
- 3.4 RNA-based Biopharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers RNA-based Biopharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global RNA-based Biopharmaceuticals Market Size by Type (2015-2020)
- 4.1.1 Global RNA-based Biopharmaceuticals Sales by Type (2015-2020)
- 4.1.2 Global RNA-based Biopharmaceuticals Revenue by Type (2015-2020)
- 4.1.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2021-2026)
- 4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2021-2026)
- 4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2021-2026)
- 4.2.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global RNA-based Biopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global RNA-based Biopharmaceuticals Market Size by Application (2015-2020)
- 5.1.1 Global RNA-based Biopharmaceuticals Sales by Application (2015-2020)
- 5.1.2 Global RNA-based Biopharmaceuticals Revenue by Application (2015-2020)
- 5.1.3 RNA-based Biopharmaceuticals Price by Application (2015-2020)
- 5.2 RNA-based Biopharmaceuticals Market Size Forecast by Application (2021-2026)
- 5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2021-2026)
- 5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2021-2026)
- 5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America RNA-based Biopharmaceuticals by Country
- 6.1.1 North America RNA-based Biopharmaceuticals Sales by Country
- 6.1.2 North America RNA-based Biopharmaceuticals Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America RNA-based Biopharmaceuticals Market Facts & Figures by Type
- 6.3 North America RNA-based Biopharmaceuticals Market Facts & Figures by Application
7 Europe
- 7.1 Europe RNA-based Biopharmaceuticals by Country
- 7.1.1 Europe RNA-based Biopharmaceuticals Sales by Country
- 7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Type
- 7.3 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific RNA-based Biopharmaceuticals by Region
- 8.1.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
- 8.1.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Type
- 8.3 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America RNA-based Biopharmaceuticals by Country
- 9.1.1 Latin America RNA-based Biopharmaceuticals Sales by Country
- 9.1.2 Latin America RNA-based Biopharmaceuticals Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America RNA-based Biopharmaceuticals Market Facts & Figures by Type
- 9.3 Central & South America RNA-based Biopharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa RNA-based Biopharmaceuticals by Country
- 10.1.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country
- 10.1.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Type
- 10.3 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
- 11.1.5 Pfizer Related Developments
- 11.2 Roche
- 11.2.1 Roche Corporation Information
- 11.2.2 Roche Description and Business Overview
- 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche RNA-based Biopharmaceuticals Products Offered
- 11.2.5 Roche Related Developments
- 11.3 Sanofi-Aventis
- 11.3.1 Sanofi-Aventis Corporation Information
- 11.3.2 Sanofi-Aventis Description and Business Overview
- 11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
- 11.3.5 Sanofi-Aventis Related Developments
- 11.4 Abbott Laboratories
- 11.4.1 Abbott Laboratories Corporation Information
- 11.4.2 Abbott Laboratories Description and Business Overview
- 11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
- 11.4.5 Abbott Laboratories Related Developments
- 11.5 Arrowhead Pharmaceuticals
- 11.5.1 Arrowhead Pharmaceuticals Corporation Information
- 11.5.2 Arrowhead Pharmaceuticals Description and Business Overview
- 11.5.3 Arrowhead Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
- 11.5.5 Arrowhead Pharmaceuticals Related Developments
- 11.6 Benitec Biopharma
- 11.6.1 Benitec Biopharma Corporation Information
- 11.6.2 Benitec Biopharma Description and Business Overview
- 11.6.3 Benitec Biopharma Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
- 11.6.5 Benitec Biopharma Related Developments
- 11.7 Calimmune Inc
- 11.7.1 Calimmune Inc Corporation Information
- 11.7.2 Calimmune Inc Description and Business Overview
- 11.7.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
- 11.7.5 Calimmune Inc Related Developments
- 11.8 Dicerna
- 11.8.1 Dicerna Corporation Information
- 11.8.2 Dicerna Description and Business Overview
- 11.8.3 Dicerna Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
- 11.8.5 Dicerna Related Developments
- 11.9 Gradalis
- 11.9.1 Gradalis Corporation Information
- 11.9.2 Gradalis Description and Business Overview
- 11.9.3 Gradalis Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
- 11.9.5 Gradalis Related Developments
- 11.10 Quark
- 11.10.1 Quark Corporation Information
- 11.10.2 Quark Description and Business Overview
- 11.10.3 Quark Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Quark RNA-based Biopharmaceuticals Products Offered
- 11.10.5 Quark Related Developments
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
- 11.1.5 Pfizer Related Developments
- 11.12 Senesco
- 11.12.1 Senesco Corporation Information
- 11.12.2 Senesco Description and Business Overview
- 11.12.3 Senesco Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Senesco Products Offered
- 11.12.5 Senesco Related Developments
- 11.13 Silence Therapeutics
- 11.13.1 Silence Therapeutics Corporation Information
- 11.13.2 Silence Therapeutics Description and Business Overview
- 11.13.3 Silence Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Silence Therapeutics Products Offered
- 11.13.5 Silence Therapeutics Related Developments
- 11.14 Silenseed
- 11.14.1 Silenseed Corporation Information
- 11.14.2 Silenseed Description and Business Overview
- 11.14.3 Silenseed Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Silenseed Products Offered
- 11.14.5 Silenseed Related Developments
- 11.15 Tekmira
- 11.15.1 Tekmira Corporation Information
- 11.15.2 Tekmira Description and Business Overview
- 11.15.3 Tekmira Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Tekmira Products Offered
- 11.15.5 Tekmira Related Developments
- 11.16 Alnylam Pharmaceuticals
- 11.16.1 Alnylam Pharmaceuticals Corporation Information
- 11.16.2 Alnylam Pharmaceuticals Description and Business Overview
- 11.16.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Alnylam Pharmaceuticals Products Offered
- 11.16.5 Alnylam Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 RNA-based Biopharmaceuticals Market Estimates and Projections by Region
- 12.1.1 Global RNA-based Biopharmaceuticals Sales Forecast by Regions 2021-2026
- 12.1.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Regions 2021-2026
- 12.2 North America RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
- 12.2.1 North America: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
- 12.2.2 North America: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
- 12.2.3 North America: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.3 Europe RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
- 12.3.1 Europe: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
- 12.3.2 Europe: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
- 12.3.3 Europe: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: RNA-based Biopharmaceuticals Market Size Forecast by Region (2021-2026)
- 12.5 Latin America RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
- 12.5.1 Latin America: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
- 12.5.2 Latin America: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
- 12.5.3 Latin America: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key RNA-based Biopharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 RNA-based Biopharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on RNA-based Biopharmaceuticals . Industry analysis & Market Report on RNA-based Biopharmaceuticals is a syndicated market report, published as Global (United States, European Union and China) RNA-based Biopharmaceuticals Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of RNA-based Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
